Sugammadex , 98% , 343306-71-8
CAS NO.：343306-71-8
Empirical Formula: C72H112O48S8
Molecular Weight: 2002.15
MDL number:
EINECS: 253-874-2
| Pack Size | Price | Stock | Quantity |
| 100mg | RMB773.60 | In Stock |
|
| 250mg | RMB1547.20 | In Stock |
|
| 1g | RMB4640.00 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | >208°C (dec.) |
| Density | 1.559±0.06 g/cm3(Predicted) |
| storage temp. | Inert atmosphere,Room Temperature |
| solubility | Aqueous Acid (Slightly), Water (Slightly, Sonicated) |
| pka | 3.42±0.10(Predicted) |
| form | Solid |
| color | White to Pale Beige |
| Stability: | Hygroscopic |
Description and Uses
Sugammadex is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery in adults. Rocuronium bromide and vecuronium bromide are neuromuscular blocking medications that cause temporary paralysis and are especially useful for general anesthesia, ventilation, or tracheal intubation that patients may require for surgery. Sugammadex provides a new treatment option to reverse the effects of those medications and possibly help patients recover sooner post-surgery. Sugammadex (brand name Bridion) is marketed by Merck Sharp and Dohme, and was approved by the United States FDA on December 15, 2015.
Reversal agent for neuromuscular blocking drugs.
